Tuesday, February 17, 2015

Educational Project Will Assist Lymphoma Patients in China

Kai-Fu Lee, Google China's founder, still battling lymphoma cancer
In the fall of 2013, Kai-Fu Lee, the Chinese venture capitalist best known for his role as founding president of Google China and his work with Microsoft and Apple, announced that he had lymphoma. The shock among the 50 million people who read his popular blog demonstrated that information about this common and often treatable cancer globally is still scarce.

In China, a country with 1.4 billion people, the incidence of lymphoma is increasing by more than six percent each year, according to Dr. Zhu Jun, director of the Beijing Cancer Hospital's lymphoma department. But that is not widely known. Jun told the South China Morning Post that knowledge of the disease even among doctors in China is sketchy.


A recent epidemiology survey concluded that lymphoma (Hodgkin's and non-Hodgkin's) is now the ninth most common cancer among Chinese males on the mainland. That's still not quite as high, percentage-wise, as the United States, where lymphoma is the seventh most common cancer in males as well as females. But it is on the rise, and that's cause for concern.


Researchers are seeing an especially significant increase in the disease among China's young people in urban areas such as Beijing. Lymphoma experts in China attribute that largely to environmental pollution. As I reported for Newsweek, China's air remains polluted, but of course the air in many parts of the world is polluted. 



The good news is that not only is Kai-Fu Lee now in remission, China is embracing solar power and other clean energies. And, China is also stepping up its efforts to educate its citizens about lymphoma. A clinical diagnosis and treatment guideline was issued jointly a few years ago by the Chinese Society of Hematology under the Chinese Medical Association and the Chinese Anti-Cancer Association

But it appears that a lot of China's residents to this point still don't have a good understanding of just what lymphoma is. To be honest, I didn't know much about it, either, until I was diagnosed with it in late 1996. My original oncologist told me I had stage IV follicular low-grade non-Hodgkin's lymphoma -- a very common type, I would come to learn -- and that I'd be very luck to live three years. 


But 18 and 1/2 years later, I'm happily still here. And the most meaningful goal in my life right now is to help others win this fight, too, whether they're in San Diego or Shenzhen. 


I'm about to embark on a historic educational project to increase awareness of lymphoma in China. We are simply reaching out to lymphoma cancer patients in China and their loved ones in a gesture of friendship and giving them some information and inspiration. I do not want to tell them what to do, I just want to help them as best I can with the psychological-social aspects of being diagnosed, give them some information about the disease, and show them that lymphoma really is treatable and beatable. 


I've had a lifelong deep affection and respect for China's people and culture, and have visited there and love China's people. I covered the Beijing Olympics as a journalist, and all I want to do now is reach out and support the Chinese people.


Hope Begins


My battle with cancer, which has been a roller coaster ride, is chronicled in my book, Hope Begins in the Dark, which I'm proud to say has become embraced globally. Why? I guess because of my very simple but true message: There is hope! But also because the world isn't as aware of the disease as it should be.


The book profiles 40 lymphoma survivors, including such famous folks as Microsoft co-founder Paul Allen and Chicago Cubs All-Star baseball player Anthony Rizzo. In the book we talk with survivors openly about what treatments each person chose, how each of us dealt with the psychological impact of being diagnosed with cancer and what it's like to face possible death, how it affected our children and families, and much more.


China's people are just beginning to understand how treatable lymphoma is and just what is available for them.


Since my cancer diagnosis and subsequent recurrences, I've committed myself to finding and helping people who don't generally have access to this type of information and yet want to be informed, inspired and reminded that cancer is not a death sentence. And it isn't! Not any more!



There is obviously a hunger in China, and across the world, for information about how to fight cancer. And this project is of course not political in any way. I've established an alliance with many prestigious global partners that will hopefully lead to positive outcomes for people who are suffering and have a deep desire to learn more about their options and about ways of coping when you receive a cancer diagnosis. 

It can be overwhelming, believe me. And scary. But also uplifting. And it makes you appreciate the precious gift that is our life.


We will be producing an all-new version of Hope Begins in the Dark that profiles China lymphoma survivors. It will be available for FREE as a hard copy and ebook to China's cancer patients and their families.

Eastern Medicine / Western Medicine


I'm happy to report that there are a bunch of new and less toxic treatments for lymphoma developed by American and European drug companies and biotech firms that did not exist when I was first diagnosed with stage IV non-Hodgkin's lymphoma in 1996. And still others are in late-stage clinical trials.


Meanwhile, China is becoming an increasingly important part of this and has established a number of exciting partnerships with United States drug companies to fight this disease. It was reported recently by ChinaBioToday that Cellular Biomedicine Group (CBMG), a China-US cell therapy company, acquired a cancer immunotherapy technology from the Chinese PLA General Hospital in Beijing. 


This purchase will lead to further development in China of this therapy, which has shown great promise in early trials for Hodgkin's lymphoma as well as acute lymphoblastic leukemia and advanced lung cancer. 



Another prominent cancer hospital in China, the Beijing Cancer Hospital I mentioned above, which is one of the largest cancer research and treatment centers in China, is establishing partnerships with such prestigious American cancer institutions as MD Anderson Cancer Center and Memorial Sloan-Kettering Cancer Center.

And if that weren't enough, Innovent, one of China's largest biotechs, recently announced that it has raised the needed capital to continue studying eight antibody products, including one for non-Hodgkin's lymphoma.

Innovent CEO Michael Yu, reportedly the only Chinese national to have invented and developed two biologic drugs, recently told PharmaExec.com that the Chinese regulatory environment has improved greatly. That's good news for cancer patients and research.

And Spectrum Pharmaceuticals, about which I have written often in the past, recently announced that it is bringing Zevalin, its very effective radio-immunotherapy treatment for lymphoma, to China in a partnership with Casi Pharmaceuticals, an American company that focuses exclusively on China.


Wait, there's even more. As China Economic Net recently reported, two Chinese scientists, Wang Zhenyi and Chen Zhu, won a top U.S. award recently by the U.S. National Foundation for Cancer Research for creating a remarkable new treatment that combines Traditional Chinese Medicine (TCM) with Western medicine. 


The new therapy increased the five-year survival rate of patients with acute promyelocytic leukemia (APL) from 25 percent to 95 percent. In clinical trials, the Chinese researchers showed that arsenic trioxide, which has been used in TCM regimens for more than 2,000 years, is effective against APL.


The treatment is now a standard for APL treatment around the world, China Economic Net reported, and "has turned one of the most fatal diseases into a highly curable one."

These and other examples show that China is becoming a legitimate player in the treatment of cancer. The country clearly has one foot firmly planted now in the world of modern medicine. But the other foot remains ensconced in its ancient healing traditions. And that's a good thing. 


As I've said many times since I was diagnosed with cancer 18 and 1/2 years ago, we can learn a lot from China's ancient healing methods, as well as its modern medical ventures. And China can of course learn much from us.


It's all about cooperation, and friendship. It's all about sharing the best from both worlds, both cultures. And that extends far beyond healthcare. It also includes art, music, literature and so much more. 


China or Bust


When my cancer returned for the first time back in 1999, I planned a fact-finding trip to China, where I was going to study Traditional Chinese Medicine. But I never made that trip. Instead, I was saved by a combination of Western and Eastern modalities. 


Much to the dismay of my former oncologist, who was allegedly renown but frankly clueless, I enrolled in a stage III clinical trial for Bexxar, a radio-immunotherapy drug like Zevalin developed by an American doctor and researcher named Mark Kaminski at the University of Michigan. The drug saved my life. Mark is a genius and I owe such a debt of gratitude to him.


But I also embraced "alternative" medicine, including a variety of immune system-boosting supplements and other things that American doctors generally don't endorse. I took something called DCA, which I've written about on this news blog before and which saved the life of my very close friend Tim McGough, who has fought the same type of lymphoma as me and who is profiled in my book. 


I was and remain an avid user of Chinese herbs, too, which have shown to be effective for some patients in boosting immune system activity and fighting lymphoma. 


And then there's acupuncture, which of course is part of the Chinese medical approach that has been around for thousands of years. There is no evidence that acupuncture actually directly kills the tumors, at least not of which I am aware. But according to Everyday Health, acupuncture is a scientifically proven way of relieving many lymphoma symptoms and side effects of treatment. 


That includes everything from pain, fatigue, depression and nausea to stomach discomfort, immunity levels and more.


For me, battling lymphoma has always been about loading up your arsenal with as many weapons as possible. And that means culling the best from the East and the West. The combined use of Western and Chinese medicines in the treatment of lymphoma, and all cancers, bears further investigation in the United States.


One of my primary life goals now is to spread this gospel of embracing the best of both Western and Eastern medicine. I just want to help as many cancer patients and their families as I can to enjoy a better quality of life. With information. Inspiration. Whatever they need. Because cancer is treatable, and beatable. You can win this fight!


3 comments:

  1. This a fabulous article and endeavor! Very encouraging and interesting. Please keep your readership updated! Leslie S, Des Moines

    ReplyDelete
    Replies
    1. Thanks, Leslie. Will do. Keep reading this news blog for updates.

      Delete
  2. That's good news for cancer patients and research. The hematology oncology personal statement will help them to cure these diseases as soon as they can .

    ReplyDelete